UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Patrick Kupelian, M.D.

Specialty:

Radiation Oncology

General Information:

Gender:	Male
Language(s):	English, French, Armenian, Arabic

Affiliation(s):

Vice Chair, Radiation Oncology

Member, JCCC Cancer Molecular Imaging Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Education:

Fellowship:	Radiation Oncology, Cleveland Clinic Foundation, 1994 - 1996
Residency:	Radiation Oncology, University of Texas - M.D. Anderson Cancer Center, 1990 - 1994
Internship:	Rotating, American University of Beirut Medical School, 1989 - 1990
Medical Degree:	M.D., American University of Beirut Medical School, 1989

Certification(s):

Medical Board Certification(s):	Radiation Oncology, American Board of Radiology, 1995, 2004

Contact Information:

Phone:	(310) 825-9771
Email:	pkupelian@mednet.ucla.edu
Website:	http://www.uclahealth.org/body.cfm?xyzpdqabc=0&id=479&action=detail&ref=122447

Practice Information:

Clinical Interest(s):	Genitourinary malignancies

Scientific Interest(s):

Although Dr. Patrick Kupelian specializes in genitourinary malignancies, he an internationally known expert in the development and evaluation of cutting edge technologies in radiation oncology for a variety of anatomic sites. He has pioneered high-dose hypofractionated radiation therapy for prostate cancers and has played a significant role in the introduction and implementation of multiple image guidance techniques in radiotherapy. He has authored more than 150 research papers, more than 300 abstracts and multiple review papers and book chapters.

Selected Cancer-Related Publications:

Potters L, Gaspar LE, Kavanagh B, Galvin JM, Hartford AC, Hevezi JM, Kupelian PA, Mohiden N, Samuels MA, Timmerman R, Tripuraneni P, Vlachaki MT, Xing L, Rosenthal SA; American Society for Therapeutic Radiology and Oncology; American College of Radiology. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):319-25.

Klein EA, Ciezki J, Kupelian PA, Mahadevan A. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy? Urol Oncol. 2009 Jan-Feb;27(1):67-71.

Kupelian PA, Langen KM, Willoughby TR, Zeidan OA, Meeks SL. Image-guided radiotherapy for localized prostate cancer: treating a moving target. Semin Radiat Oncol. 2008 Jan;18(1):58-66.

Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1146-50.

Thames HD, Kuban D, Levy LB, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol. 2010 Jul;96(1):6-12.